Skip to main navigation Skip to search Skip to main content

Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies

  • John Jeongseok Yang
  • , Tae Sung Park
  • , Seung Tae Lee
  • , Ja Young Seo
  • , Seung Hwan Oh
  • , Eun Hae Cho
  • , Thomas Burmeister
  • , Wolf Dieter Ludwig
  • , Claus Meyer
  • , Rolf Marschalek
  • , Hee Jin Kim
  • , Sun Hee Kim
  • Kyung Hee University
  • Sungkyunkwan University
  • Inje University
  • Green Cross Genome Corporation
  • Charité – Universitätsmedizin Berlin
  • Fresenius AG
  • Goethe University Frankfurt

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e49-e51
JournalHaematologica
Volume99
Issue number4
DOIs
StatePublished - Apr 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ACTN4
  • MLL
  • Therapy-related

Cite this